Search





Search





Markets
/
Stocks
/
nasdaq-abt
/

Abbott Laboratories

ABT

Add to Watchlist

88.410USD

-0.120-0.14%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

153.99BMarket Cap

24.53P/E TTM

Abbott Laboratories

88.410

-0.120-0.14%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey 图表

Intraday

30m

Today

-0.14%

5 Days

+0.26%

1 Month

-0.46%

6 Months

-29.53%

Year to Date

-29.44%

1 Year

-33.23%

Key Figures

88.640Open

89.440High

41.96MVolume

24.53P/E TTM

14.54P/E Dynamic

2.440Dividend TTM

2.41%Turnover Ratio

88.500Prev. Close

87.760Low

1.47BTurnover

11.49P/E Static

2.96P/B

2.76%Div Yield TTM

6.54%ROA

139.06052wk High

2.27Volume Ratio

13.40BNet Profit

1.74BShares

3.6035EPS TTM

0.63Beta

12.44%ROE

81.97052wk Low

1.90%Amplitude

52.42%Gross Margin

153.99BMarket Cap

0.69Reward/Risk

1.21%Risk Rate

TradingKey Stock Score of Abbott Laboratories

Currency: USD Updated: 2026-06-18

Key Insights

Abbott Laboratories's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 117.68.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Abbott Laboratories's Score

Industry at a Glance

Industry Ranking

24 / 203

Overall Ranking

90 / 4578

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

43°C



Very Low

Very High

Neutral

Abbott Laboratories Highlights

StrengthsRisks

Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.

Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 44.33B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 29.13%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 29.13%.

Fairly Valued

The company’s latest PE is 24.53, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.25B shares, decreasing 13.03% quarter-over-quarter.

Held by Diamond Hill Capital

Star Investor Diamond Hill Capital holds 6.41M shares of this stock.

Analyst Rating

Based on 30 analysts

Buy

Current Rating

117.682

Target Price

+32.97%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Abbott Laboratories News

How Artificial Intelligence Benefits Health Care: 10 AI Healthcare Stocks to Watch

TradingKey - With the rapid development of artificial intelligence (AI), beyond the well-known large language models such as ChatGPT and DeepSeek, people are continuously exploring new AI applications and investigating how the cutting-edge technologies driving the "Fourth Industrial Revolution"...

TradingKeyMar 12, 2025